Skip to main content

Table 1 Comparisons of baseline data in the two groups [(\({\overline{\text{x}}}\) ±SD), n(%)]

From: Clinical efficacy and complications of transurethral resection of the prostate versus plasmakinetic enucleation of the prostate

Parameters

TURP group (320)

PKEP group (530)

t or x2

P

Age (year)

67.94 ± 10.16

68.75 ± 8.97

1.213

0.226

Duration of BPH (year)

9.89 ± 3.24

10.11±4.06

0.882

0.411

Volume of prostate (mL)

62.23 ± 19.25

60.44 ± 17.79

1.362

0.173

Catheterization (n)

51(15.94)

69(13.02)

1.049

0.306

Bladder stone (n)

45(16.06)

52(9.81)

2.811

0.094

Hypertension (n)

86(26.88)

163(30.75)

1.450

0.229

Diabetes (n)

75(23.44)

102(19.25)

1.382

0.240

Coronary heart disease (n)

63(19.69)

115(21.70)

0.487

0.485

Serum tPSA (ng/L)

2.07±0.82

1.98±0.75

1.636

0.102

VAS score (points)

2.63±0.61

2.56±0.41

1.300

0.235

Erectile dysfunction (n)

89(27.81)

163(30.75)

0.828

0.363

Retrograde ejaculation (n)

25(7.81)

39(7.36)

0.051

0.822

ASA classification (I ~ II)

231(72.19)

408(76.98)

0.351

0.554

ASA classification (III ~ IV)

89(27.81)

128(24.15)

0.829

0.363

  1. TURP transurethral resection of prostate; PKEP plasmakinetic enucleation of the prostate; tPSA total prostate specific antigen; ASA the American Society of Anesthesiologists